| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
disease | 0.300 | None | 1.000 | 19 | 1 | 2001 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
disease | 0.300 | None | 1.000 | 19 | 0 | 2013 | 2020 | ||||||||
|
thrombomodulin | 0.457 | 0.769 | 5.4E-02 |
|
disease | 0.300 | None | 1.000 | 19 | 0 | 2007 | 2019 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
disease | 0.300 | None | 0.944 | 18 | 2 | 1997 | 2019 | ||||||||
|
interleukin 17A | 0.324 | 0.923 | 4.3E-02 |
|
disease | 0.300 | None | 1.000 | 16 | 0 | 2005 | 2020 | ||||||||
|
advanced glycosylation end-product specific receptor | 0.420 | 0.885 | 6.4E-16 |
|
disease | 0.300 | None | 1.000 | 14 | 3 | 2009 | 2019 | ||||||||
|
intercellular adhesion molecule 1 | 0.364 | 0.962 | 3.5E-02 |
|
disease | 0.300 | None | 1.000 | 12 | 0 | 2005 | 2019 | ||||||||
|
interleukin 1 receptor antagonist | 0.373 | 0.923 | 3.1E-02 |
|
disease | 0.300 | None | 0.917 | 12 | 0 | 1999 | 2019 | ||||||||
|
adenosine A2a receptor | 0.526 | 0.769 | 0.60 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
adenosine A2b receptor | 0.617 | 0.692 | 1.8E-05 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
interferon alpha 2 | 0.442 | 0.885 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 1987 | 1987 | |||||||||
|
mitogen-activated protein kinase 3 | 0.379 | 0.885 | 3.7E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2004 | 2004 | ||||||||
|
complement C5a receptor 1 | 0.513 | 0.808 | 0.40 |
|
disease | 0.290 | None | 1.000 | 11 | 0 | 2001 | 2019 | ||||||||
|
coagulation factor V | 0.441 | 0.846 | 5.9E-15 |
|
disease | 0.290 | None | 1.000 | 10 | 0 | 2002 | 2015 | ||||||||
|
glutamic--pyruvic transaminase | 0.403 | 0.923 | 3.6E-19 |
|
disease | 0.290 | None | 1.000 | 10 | 0 | 2015 | 2019 | ||||||||
|
complement factor H | 0.441 | 0.885 | 0.86 |
|
disease | 0.290 | None | 1.000 | 10 | 2 | 2003 | 2020 | ||||||||
|
nucleotide binding oligomerization domain containing 2 | 0.423 | 0.923 | 2.0E-30 |
|
disease | 0.280 | None | 1.000 | 9 | 2 | 2004 | 2014 | ||||||||
|
coagulation factor II, thrombin | 0.415 | 0.885 | 1.1E-03 |
|
disease | 0.260 | None | 1.000 | 7 | 0 | 2005 | 2019 | ||||||||
|
ectonucleoside triphosphate diphosphohydrolase 1 | 0.499 | 0.769 | 8.1E-03 |
|
disease | 0.260 | None | 0.857 | 7 | 0 | 2012 | 2019 | ||||||||
|
complement C5 | 0.550 | 0.731 | 8.1E-24 |
|
disease | 0.250 | None | 1.000 | 7 | 0 | 2001 | 2018 | ||||||||
|
endothelin 1 | 0.380 | 0.846 | 0.46 |
|
disease | 0.250 | None | 1.000 | 6 | 0 | 2000 | 2018 | ||||||||
|
mechanistic target of rapamycin kinase | 0.343 | 0.885 | 1.00 |
|
disease | 0.250 | None | 1.000 | 6 | 0 | 2007 | 2019 | ||||||||
|
nuclear receptor subfamily 3 group C member 1 | 0.393 | 0.885 | 0.97 |
|
disease | 0.250 | None | 1.000 | 6 | 0 | 2004 | 2018 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
disease | 0.250 | None | 1.000 | 6 | 1 | 2005 | 2017 | ||||||||
|
cathelicidin antimicrobial peptide | 0.466 | 0.846 | 4.4E-03 |
|
disease | 0.250 | None | 1.000 | 6 | 0 | 2006 | 2019 |